share_log

康龍化成:2021年度董事會及監事會工作報告;2021年度財務決算報告;2021年度利潤分配預案;建議授出發行額外換股股份的可轉換債券相關特別授權;2021年年度報告全文、報告摘要及2021年年度業績公告;2022年度董事及監事薪酬;委聘2022年度境內及

Pharmaron Beijing Co., Ltd.*: REPORT OF BOARD & SUPERVISORY COMMITTEE;FINANCIAL STATEMENTS;PROFIT DISTRIBUTION PLAN;GRANT OF CONVERTIBLE BONDS-RELATED SPECIFIC MANDATE;REPORT & ANNUAL RESULTS ANNOUNCEMENT;REMUNERATION OF DIRECTORS & SUPERVISORS;ENGAGEMENT

May 6, 2022 05:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more